⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Quant Equity Savings Fund - Growth - Direct Plan | Qsif Hybrid Long-Short Fund - Regular Plan - IDCW |
|---|---|---|
| Snapshot | ||
| AMC | Quant MF | QSIF |
| Category | Hybrid - Equity Savings | Hybrid - Long-Short Fund |
| NAV | ₹10.91 (30 Oct 2026) | ₹12.61 (30 Oct 2026) |
| Rating | ★★★ | ★★★ |
| Benchmark | NIFTY 50 Equity Savings Index - TRI | NIFTY 50 Hybrid Composite Debt 50:50 Index |
| Fund Manager | Sanjeev Sharma | Sandeep Tandon |
| Inception | 24 Jul 2025 | 15 Oct 2025 |
| Returns | ||
| 1Y | 6.30% | 26.41% |
| 3Y | — | — |
| 5Y | — | — |
| Since Inception | 7.23% | 26.03% |
| Risk | ||
| 5.95 | 19.65 | |
| 0.36 | -0.48 | |
| 0.17 | 2.24 | |
| 5.13 | 39.13 | |
| 0.33 | 8.37 | |
| -4.96% | -2.41% | |
| Costs | ||
| Expense Ratio | 1.99% | 3.66% |
| Exit Load | 1% on or before 15D, Nil after 15D | 3% on or before 30D, NIL after 30D |
| Min SIP | ₹1,000 | ₹1,000 |
| Min Lumpsum | ₹5,000 | ₹10,00,000 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Quant MF79%
QSIF79%
20.9%Only 20.9% of holdings by weight are common between Quant MF and QSIF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingQuant MFQSIF
TREPS 01-Oct-2026 DEPO 1015.86%36.65%
Gujarat Themis Biosyn Ltd.7.69%3.36%
Glaxosmithkline Pharmaceuticals Ltd.1.76%1.68%
Category context: Hybrid vs Hybrid. Open the full Screener →